CRL-40,941
From Wikipedia, the free encyclopedia
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
(Learn how and when to remove this template message)
|
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | Fluorafinil, Fladrafinil |
CAS Number | 90212-80-9 |
PubChem (CID) | 13316557 |
ChemSpider | 29785194 |
Chemical and physical data | |
Formula | C15H13F2NO3S |
Molar mass | 325.33 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
CRL-40,941 (also known as fladrafinil and fluorafinil) is a wakefulness-promoting agent closely related to adrafinil and modafinil. It is the bis(p-fluoro) ring-substituted derivative of adrafinil. CRL-40,941 was found to produce antiaggressive effects in animals, which adrafinil does not produce.[1]
See also[edit]
References[edit]
- ^ US patent 4489095, Lafon, L., "Halogenobenzhydrylsulfinylacetohydroxamic Acids", issued 1984-12-18, assigned to Laboratoire L. Lafon
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |